ポスター：Genedataによるバイオ医薬品およびワクチンの創出・研究開発の加速

Biologics Digitalization & AI World 2025
3月 12, 2025

Genedata Platformは、多種多様な新規モダリティにおける創薬ならびに研究開発をデジタル化します。本ポスターでは、Genedataの7つのエンタープライズソフトウェアソリューションの概要を紹介しています。

Digital innovation in biopharmaceutical and vaccine R&D has the power to accelerate scientific progress and improve the overall R&D success rate through better data integration, analysis, accessibility, and traceability. It also enables intelligent automation of experimental workflows.

Here we present the Genedata Biopharma Platform, a dedicated enterprise-focused solution that consists of seven software systems, working separately and together to provide significant benefits in R&D. Genedata Biologics^®, Genedata Screener^®, and Genedata Imagence^® support key research workflows and assay analysis primarily in the earlier phases of R&D. Genedata Bioprocess^® and Genedata Selector^® are utilized in bioprocess development, including CLD, USP, DSP, formulation, and analytics development. Genedata Profiler^® supports translational and exploratory clinical work by integrating drug response, patient, multi-omics, and image data across clinical and pre-clinical workflows. Finally, Genedata Expressionist^® is used for MS-based characterization and quality control of diverse biotherapeutics and vaccines throughout R&D. The Genedata Biopharma Platform integrates easily into existing IT environments using open APIs and promotes internal and external collaboration across organizations.